Although lack of consistency between in vitro 2D versus in vivo findings are not unusual, another possible explanation for this paradox (inhibition of EMT versus tumor promotion) is that the loss of CD109 leads to complete EMT, resulting in the loss of epithelial traits and the acquisition of a terminal mesenchymal phenotype [18]. The gene discussed is CD109; the disease is neoplasm.